← Back to Search

Immediate Intervention Group for Arthritis

N/A
Waitlist Available
Led By Linda Li, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, months 3, 6, and 9
Awards & highlights

Study Summary

Physical activity is an essential first-line treatment for patients with knee osteoarthritis (OA). However, only 13% of patients meet the activity recommendation of 150 minutes or more per week. The primary goal of this randomized controlled trial is to assess the efficacy of a Fitbit Flex (a wireless physical activity tracking device) paired with a new application, plus a brief education session and telephone counselling by a physiotherapist (PT), to improve physical activity and reduce sedentary time in patients with knee osteoarthritis.

Eligible Conditions
  • Arthritis
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, months 3, 6, and 9
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, months 3, 6, and 9 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time spent in Moderate to Vigorous Physical Activity (MVPA)
Secondary outcome measures
Knee Injury and OA Outcome Score (KOOS)
Partners in Health Scale
The Patient Health Questionnaire-9 (PHQ-9)
+3 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Immediate Intervention GroupActive Control1 Intervention
Education session, Fitbit/FitViz, PT counselling: Participants receive this intervention in Months 1-3. The session will include a presentation on physical activity, an individual goal-setting session with a registered physiotherapist, and an orientation to the Fitbit Flex and the FitViz app. In Months 1 and 2, participants will use the Fitbit/FitViz. The PT will review the progress with participants via 20-minute bi-weekly phone calls, and progressively modify their activities. In Month 3, participants will continue using the Fitbit/FitViz and have access to a PT via email as needed, but no bi-weekly phone calls. In Months 4-9, participants may continue using the Fitbit/FitViz without access to a PT.
Group II: Delayed Intervention GroupPlacebo Group1 Intervention
Same intervention with a 3 month delay: The full intervention will be initiated in Month 4 and with a brief education session, use of a Fitbit Flex paired with the FitViz app, and counseling by a physiotherapist. In Months 6-9, participants will continue using Fitbit/FitViz without the PT phone calls.

Find a Location

Who is running the clinical trial?

Arthritis Research Centre of CanadaOTHER
12 Previous Clinical Trials
9,358 Total Patients Enrolled
5 Trials studying Arthritis
8,478 Patients Enrolled for Arthritis
Simon Fraser UniversityOTHER
53 Previous Clinical Trials
10,385 Total Patients Enrolled
4 Trials studying Arthritis
926 Patients Enrolled for Arthritis
Fraser HealthOTHER
45 Previous Clinical Trials
707,430 Total Patients Enrolled
2 Trials studying Arthritis
250 Patients Enrolled for Arthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
SuPRA: Using Wearable Activity Trackers With a New Application to Improve Physical Activity in Knee Osteoarthritis
Linda Li 2017. "SuPRA: Using Wearable Activity Trackers With a New Application to Improve Physical Activity in Knee Osteoarthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02585323.
All > Arthritis > Knee Osteoarthritis
~7 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top